Market Overview

11 Biggest Mid-Day Gainers For Thursday



  • SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 175.8 percent to $9.10 after filing of large insider buy released. Dr. Peter Chiou will purchase 577,000 shares of SemiLEDs common stock at $5.00 per share.
  • U.S. Energy Corp. (NASDAQ: USEG) shares climbed 42.4 percent to $2.52 as the company agreed to acquire interest in Wattenberg development program.
  • AVG Technologies NV (NYSE: AVG) shares surged 31.5 percent to $24.71 after Avast Software announced plans to acquire AVG Technologies for $1.3 billion in cash.
  • WhiteWave Foods Co (NYSE: WWAV) shares gained 18.6 percent to $56.26 after France's Danone SA announced its plans to buy WhiteWave Foods for $56.25 per share in cash.
  • Paramount Gold Nevada Corp (NYSE: PZG) rose 16.5 percent to $2.47 as the company reported that it has has completed the acquisition of Calico Resources Corp.
  • EZCORP Inc (NASDAQ: EZPW) climbed 16.1 percent to $8.87 as the company entered into agreement to sell Grupo Finmart for $50 million. Wells Fargo upgraded EZCORP from Market Perform to Outperform.
  • LivePerson, Inc. (NASDAQ: LPSN) rose 14 percent to $7.13. Benchmark upgraded LivePerson from Hold to Buy.
  • EMCORE Corporation (NASDAQ: EMKR) gained 8.6 percent to $6.19. EMCORE announced a special dividend of $1.50 per share.
  • BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares climbed 8.3 percent to $87.49. Roche is said to have renewed interest in BioMarin, Betaville reported.
  • Pernix Therapeutics Holdings Inc (NASDAQ: PTX) shares gained 8.1 percent to $0.48 as the company reported restructuring of sales force and operations. Pernix Therapeutics announced plans to reduce workforce by 23 percent
  • PepsiCo, Inc. (NYSE: PEP) shares rose 2 percent to $108.04 as the company reported better-than-expected Q2 earnings.

Posted-In: Mid-Day GainersNews Intraday Update Markets Movers


Related Articles (BMRN + AVG)

View Comments and Join the Discussion!

U.S. Dollar Index Moves Up Ahead of Jobs Data

Technical Alert: Bimoarin Pops And Drops After Renewed Interest From Roche